Table of Contents
WASHINGTON — Healthcare Distribution Alliance (HDA) president and CEO Chester “Chip” Davis, Jr., testified today before the House Energy and Commerce Subcommittee on Health during a legislative hearing on proposals to prevent and respond to generic drug shortages.
Chip Davis
Below is an excerpt from Mr. Davis’ testimony:
“HDA and its members recognize the challenges drug shortages pose to the healthcare system, and that is why we work with manufacturers to mitigate and manage them when they occur. We applaud the [House Energy and Commerce Subcommittee on Health] for the admirable efforts to act on drug shortages but caution against policy proposals that would create unintended disruptions to the supply chain … HDA and its members stand ready to provide our continuing perspective and insight on behalf of the pharmaceutical distribution industry and partner with [the committee] on real solutions to this complicated challenge.”
Read the full testimony here.
